Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT.
Journal
Bone marrow transplantation
ISSN: 1476-5365
Titre abrégé: Bone Marrow Transplant
Pays: England
ID NLM: 8702459
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
09
02
2021
accepted:
02
08
2021
revised:
29
06
2021
pubmed:
23
8
2021
medline:
11
3
2022
entrez:
22
8
2021
Statut:
ppublish
Résumé
The current guidelines for prevention of infections in hematopoietic stem cell transplantation (HSCT) do not specify which central venous catheter (CVC) insertion site should be preferred in allogeneic HSCT recipients-internal jugular vein (IJV) or subclavian vein (SCV). We designed a multicenter prospective observational study comparing the risk of infectious and non-infectious complications between the two most common sites of CVC insertion (IJV and SCV) in allogeneic HSCT. There were in total 232 consecutive patients (86 IJV and 146 SCV) who underwent adult allogeneic HSCT reported from 11 centers in 8 countries. The center independent analysis of central line associated/related blood stream infections with ECDC criteria has shown statistically significant difference favoring SCV (23% IJV vs 13% SCV (OR 2.03 (1.01-4.06), p = 0.047)). The differences in CLABSI per 1000 days of CVC use favored SCV over IJV (7.93/1000 days IJV vs 2.79/1000 days SCV, p = 0.002). The frequency of all non-infectious complications was similar in both arms-13% IJV and 12% SCV (OR 1.1 (0.5-2.5), p = 0.8). This multicenter prospective study showed statistically significant lower confirmed number of CLABSI per 1000 days of CVC use without higher risk of noninfectious complications related to the subclavian insertion site in allogeneic HSCT recipients.
Identifiants
pubmed: 34420041
doi: 10.1038/s41409-021-01430-7
pii: 10.1038/s41409-021-01430-7
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2929-2933Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transpl. 2009;15:1143–238. https://doi.org/10.1016/j.bbmt.2009.06.019 . Available from
doi: 10.1016/j.bbmt.2009.06.019
Snarski E, Mank A, Iacobelli S, Hoek J, Styczyński J, Babic A, et al. Current practices used for the prevention of central venous catheter-associated infection in hematopoietic stem cell transplantation recipients: a survey from the Infectious Diseases Working Party and Nurses’ Group of EBMT. Transpl Infect Dis. 2015;17:558–65.
Martinho GH, Romanelli RMC, Machadoteixeira G, Macedo AV, Chaia JMC, Nobre V. Infectious complications associated with the use of central venous catheters in patients undergoing hematopoietic stem cell transplantation. Am J Infect Control 2013;32:1–3.
Heidenreich D, Hansen E, Kreil S, Nolte F, Jawhar M, Hecht de Gutierrez A, et al. Influence of the insertion site on central venous catheter-related complications in patients undergoing allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2020;26:1189–94.
doi: 10.1016/j.bbmt.2020.02.007
Parienti J-J, du Cheyron D, Timsit J-F, Traore O, Kalfon P, Mimoz O, et al. Meta-analysis of subclavian insertion and non-tunneled central venous catheter-associated infection risk reduction in critically ill adults. Crit Care Med. 2012;40:1627–34.
doi: 10.1097/CCM.0b013e31823e99cb
Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med. 2012;40:2479–85. http://www.ncbi.nlm.nih.gov/pubmed/22809915 Available from
doi: 10.1097/CCM.0b013e318255d9bc
Arvaniti K, Lathyris D, Blot S, Apostolidou-Kiouti F, Koulenti D, Haidich A-B. Cumulative evidence of randomized controlled and observational studies on catheter-related infection risk of central venous catheter insertion site in ICU patients: a pairwise and network meta-analysis. Crit Care Med 2017;45:e437–48.
doi: 10.1097/CCM.0000000000002092
Parienti JJ, Mongardon N, Mégarbane B, Mira JP, Kalfon P, Gros A, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373:1220–9.
doi: 10.1056/NEJMoa1500964
Yokoe D, Casper C, Dubberke E, Lee G, Muñoz P, Palmore T, et al. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transplant 2009;44:495–507.
doi: 10.1038/bmt.2009.261
National Healthcare Safety Network (NHSN) Patient Safety Component Manual. 2020; https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf .
Surveillance of healthcare-associated infections and prevention indicators in European intensive care units HAI-Net ICU protocol, version 2.2. 2015.
O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011;39:S1–34. 4 Suppl 1
doi: 10.1016/j.ajic.2011.01.003
Safdar N, O’Horo JC, Ghufran A, Bearden A, Didier ME, Chateau D, et al. Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*. Crit Care Med. 2014;42:1703–13.
doi: 10.1097/CCM.0000000000000319
Touré A, Chambrier C, Vanhems P, Lombard-Bohas C, Souquet J-C, Ecochard R. Propensity score analysis confirms the independent effect of parenteral nutrition on the risk of central venous catheter-related bloodstream infection in oncological patients. Clin Nutr. 2013;32:1050–4.
doi: 10.1016/j.clnu.2012.12.006
Catchpoole EM, Thirunavukarasu CE, Varelias A, Schlebusch S, Olver S, Zomerdijk N, et al. Early blood stream infections after BMT are associated with cytokine dysregulation and poor overall survival. Biol Blood Marrow Transplant. 2018;24:1360–6.
doi: 10.1016/j.bbmt.2018.02.025